Table 4.
Correlation analysis for microvascular complications and other variables in the diabetic group of PWS patients
| Variables | Correlation coefficient | |
|---|---|---|
| r | p-value* | |
| Age (years) | 0.393 | 0.047 |
| Age at diagnosis with PWS (years) | 0.226 | 0.267 |
| Age at diagnosis with T2DM (years) | 0.104 | 0.613 |
| HbA1C (%) | 0.232 | 0.254 |
| BMI, kg/m2 (SD) | 0.133 | 0.517 |
| HOMA-IR | 0.434 | 0.027 |
| Age at GHT start (years) | 0.189 | 0.439 |
| Previous GHT duration (years) | 0.376 | 0.058 |
| DM treatment duration (years) | 0.370 | 0.063 |
| From PWS diagnosis to DM diagnosis (years) | −0.156 | 0.446 |
Abbreviations: r Spearman correlation coefficient, T2DM type 2 Diabetes Mellitus, PWS Prader-Willi syndrome, HbA1C hemoglobin A1C, GHT growth hormone treatment, HOMA-IR homeostasis model assessment, BMI body mass index
*Significant association was classified as p < 0.05